Global Intravascular Catheters Market Poised for Growth as Demand for Minimally Invasive Care and Advanced Vascular Access Expands
The Global Intravascular Catheters Market is supported by rising hospital admissions, the growing burden of chronic diseases, increasing surgical procedures, and wider adoption of minimally invasive treatment. The following press release follows your requested structure, with market estimation, segmentation, and company information based on the specified Maximize Market Research report, while recent 2025 developments are used for broader industry context.
Market Estimation, Growth Drivers and Opportunities
According to Maximize Market Research, the Global Intravascular Catheters Market was valued at USD 9.39 billion in 2023 and is projected to reach nearly USD 19.99 billion by 2030, growing at a CAGR of 11.4% during 2024–2030. The market is benefiting from the increasing incidence of cancer, renal disorders, infectious diseases, and other chronic conditions that require prolonged vascular access, diagnosis, monitoring, and treatment. The growing use of minimally invasive procedures is another major driver, as intravascular catheters are essential across surgical, diagnostic, interventional, and critical-care settings.
The expansion of hospitals, ambulatory surgical centers, catheterization laboratories, and homecare services is creating additional opportunities. Technological advancement is also reshaping the industry through integrated and closed catheter systems designed to improve clinical efficiency and reduce complications. A major opportunity for manufacturers lies in developing safer vascular-access technologies with improved materials, enhanced visualization, infection-control features, and easier placement. The shift toward outpatient treatment and home-based care could further increase demand for devices that combine safety, durability, and patient comfort.
* Gain Competitive Market Advantage: https://www.maximizemarketresearch.com/request-sample/90628/
US Market Trends and Investment
The United States continues to be an important innovation center for intravascular-access and catheter technologies, supported by a large hospital network, advanced cardiovascular care, and substantial medical-device investment. Product activity in 2025 reflected continued innovation in long-term vascular access. Access Vascular, Inc. received an FDA substantial-equivalence decision in July 2025 for its Dual Lumen 5Fr HydroPICC Catheter, while Bard Access Systems received FDA clearance in September 2025 for additional implantable vascular-access port configurations.
However, the U.S. market also demonstrated the growing importance of product surveillance and safety management. In March 2025, BD and its Bard subsidiary issued an urgent recall notice involving certain PowerPICC intravascular catheters, while Cook Medical issued a 2025 recall involving Beacon Tip angiographic catheters because of potential tip separation. These developments highlight the increasing emphasis on material reliability, design validation, post-market monitoring, and patient safety.
Market Segmentation
According to the supplied Maximize Market Research report, the market is segmented by Product, Application, and End User. The product categories include Short Peripheral Intravascular Catheters (PIVC) and Integrated/Closed Peripheral Intravascular Catheters (PIVC). The report also covers applications in oncology, gastroenterology, renal disease, infectious diseases, and other conditions, along with hospitals and clinics, ambulatory surgical centers, homecare settings, and other end users.
The report does not publicly provide a verified percentage or explicit dominant global segment for these categories. Therefore, no unsupported claim regarding the largest individual product, application, or end-user segment is included.
Intravascular Catheter Market Key Players
1. Medtronic
2. Vitality Medical
3. B.Braun
4. Melsungen
5. Coloplast
6. Boston Scientific Corporation
7. Koninklijke Philips N.V
8. Abbott
9. Medtronic Plc
10. Braun Melsungen Ag
11. Becton
12. Dickinson
13. Terumo Medical Corporation
14. Lumend Corporation
15. Covidien Ag
16. Acist Medical Systems
17. Cook Medical Inc.
18. Getinge AB
19. Biotronic SE & CO.KG
20. Biosense Webster Inc.
21. Cordis
22. QX Medical
23. Teleflex Corporated
Competitive Analysis
The Maximize Market Research report identifies Medtronic, B. Braun, Boston Scientific Corporation, Abbott, Becton, Dickinson and Company, Terumo Medical Corporation, Cook Medical, Getinge, Cordis, Teleflex, and other companies as key market participants. The report does not disclose individual company market-share percentages; therefore, the following five companies are discussed as prominent participants from the report's company list rather than as an independently verified ranking of the five largest global shareholders.
Medtronic continues to develop catheter-based cardiovascular technologies and received an FDA approval supplement in 2025 for modifications related to its Sphere-9 Mapping and Ablation Catheter packaging, demonstrating continued product lifecycle management in advanced catheter systems.
B. Braun remains an important supplier of vascular-access and infusion technologies. Its established presence in hospital infrastructure positions the company to benefit from the increasing need for efficient and safer vascular-access solutions.
Abbott advanced catheter innovation in 2025 with the introduction of its TactiFlex Sensor Enabled Ablation Catheter in India. The technology combines a flexible electrode tip with contact-force sensing, illustrating the broader trend toward improved procedural precision and real-time clinical feedback in catheter-based treatment.
Becton, Dickinson and Company (BD) remains a major participant in vascular-access technologies. Its 2025 PowerPICC safety action also demonstrates how manufacturers are increasingly required to combine product innovation with rigorous quality-control and post-market surveillance processes.
Terumo Medical Corporation benefits from continued demand for catheter-based cardiovascular and interventional procedures. Its technology development reflects the industry's focus on improving visualization and procedural decision-making through more sophisticated intravascular systems.
Regional Analysis
United States: The U.S. is a major contributor to North American demand because of its extensive healthcare infrastructure, large volume of surgical and interventional procedures, and concentration of leading medical-device companies. North America held the largest regional share of the global market in 2023, according to Maximize Market Research, although the report does not publish a separate percentage for the United States alone.
United Kingdom: The UK's demand is supported by an established hospital system and continuing need for vascular access in oncology, renal care, infectious-disease treatment, and surgery.
Germany: Germany's advanced healthcare infrastructure and strong medical-device manufacturing sector support the adoption of sophisticated catheter technologies and minimally invasive procedures.
France: France provides growth opportunities through its developed healthcare system, aging population, and increasing demand for chronic-disease management and hospital-based interventions.
Japan: Japan's advanced medical technology sector and aging population support demand for catheter-based diagnosis and treatment, particularly in cardiovascular and chronic-care applications.
China: China represents a significant long-term opportunity as healthcare infrastructure expands and access to advanced diagnostic and interventional procedures increases. Growing hospital capacity and investment in medical technology can support demand for modern vascular-access devices.
Conclusion
The Global Intravascular Catheters Market is expected to nearly double in value between 2023 and 2030, rising from USD 9.39 billion to nearly USD 19.99 billion at an 11.4% CAGR.
In my view, the market's strongest growth opportunity lies in the transition toward safer, minimally invasive, technologically advanced, and patient-friendly vascular-access systems. The expansion of ambulatory care and homecare, combined with rising chronic disease prevalence, will continue to create demand. Companies that invest in improved catheter materials, infection prevention, integrated or closed systems, enhanced visualization, and technologies that simplify placement and monitoring are likely to gain significant opportunities as healthcare systems seek to improve both clinical outcomes and operational efficiency.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
? +91 9607365656
? sales@maximizemarketresearch.com
